Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU)

NYSEARCA: TBXU · Real-Time Price · USD
28.47
-0.53 (-1.83%)
Nov 7, 2025, 2:38 PM EST - Market open
-1.83%
Assets$3.46M
Expense Ratio0.97%
PE Ration/a
Shares Out125,001
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
Payout Frequencyn/a
Payout Ration/a
Volume2,090
Open28.75
Previous Close29.00
Day's Range28.26 - 28.75
52-Week Low25.71
52-Week High29.38
Betan/a
Holdings10
Inception DateOct 1, 2025

About TBXU

Fund Home Page

The Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is an exchange-traded fund that mostly invests in health care equity. TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry. TBXU was launched on Oct 1, 2025 and is issued by Direxion.

Asset Class Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol TBXU
ETF Provider Direxion
Index Tracked NYSE Biotechnology Top 5 Equal Weight Index

Top 10 Holdings

100.00% of assets
NameSymbolWeight
Dreyfus Govt Cash Man Insn/a24.27%
Goldman Finl Sq Trsry Inst 506n/a21.25%
Regeneron Pharmaceuticals, Inc.REGN9.57%
Vertex Pharmaceuticals IncorporatedVRTX9.02%
Amgen Inc.AMGN8.95%
Gilead Sciences, Inc.GILD8.89%
Alnylam Pharmaceuticals, Inc.ALNY7.78%
Dx D Biotech T 5 Bull 2x Etf Swapn/a3.62%
Cashn/a3.47%
Dx D Biotech T 5 Bull 2x Etf Swapn/a3.17%
View More Holdings

Performance

News

Trade Top 5 Industry Leaders With Direxion's New Titans ETFs

Direxion expanded its existing product lineup of leveraged and inverse exchange-traded funds (ETFs) with a new suite: the Titans Leveraged & Inverse ETFs. The funds offer a middle-ground approach that...

Other symbols: TEXUTSXDTSXUTTXDTTXU
5 weeks ago - ETF Trends

Trade the Titans: Direxion Debuts New Suite of Leveraged & Inverse ETFs

New York, United States, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Direxion, a leading provider of tactical ETFs, today announced the launch of the Direxion Titans Leveraged & Inverse ETFs, a new suite of fun...

Other symbols: TEXUTSXDTSXUTTXDTTXU
5 weeks ago - GlobeNewsWire